Cargando…
Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine
BACKGROUND: Dendritic cells (DC) pulsed with tumor-derived antigenic material have widely been used in antitumor vaccination protocols. However, the optimal strategy of DC loading has not yet been established. Our aim was to define requirements of optimal DC vaccines in terms of in vivo protection i...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1832176/ https://www.ncbi.nlm.nih.gov/pubmed/17359532 http://dx.doi.org/10.1186/1479-5876-5-16 |